40.40 - 41.05
29.80 - 47.18
2.12M / 3.68M (Avg.)
18.02 | 2.27
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-75.57%
Both companies show declining cash positions (-75.57% vs CRK's -43.11%). Seth Klarman would examine if this reflects broader market conditions or operational challenges.
No Data
No Data available this quarter, please select a different quarter.
-75.57%
Cash + STI yoy ≥ 1.5x CRK's -43.11%. David Dodd might see it as a strategic cash buffer advantage. Evaluate deployment plans.
-20.11%
Higher Net Receivables Growth compared to CRK's zero value, indicating worse performance.
10.89%
Higher Inventory Growth compared to CRK's zero value, indicating worse performance.
-22.16%
Other current assets growth < half of CRK's 280.48%. David Dodd sees a leaner approach to short-term items.
-48.38%
Below half of CRK's 1.26%. Michael Burry could suspect a liquidity squeeze. Verify operational performance.
-12.09%
Similar yoy growth to CRK's -12.65%. Walter Schloss sees parallel capital spending strategies. Check utilization rates.
0.42%
Higher Goodwill Growth compared to CRK's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
0.42%
Higher Goodwill + Intangibles Growth compared to CRK's zero value, indicating worse performance.
-15.38%
Both CRK and the company show zero Long-Term Investments Growth.
8.02%
Less than half of CRK's -99.81%. David Dodd sees fewer tax deferrals or losses, indicating stronger profitability vs. competitor.
-8.25%
Less than half of CRK's 127.90%. David Dodd sees fewer expansions in non-core assets. Possibly a simpler focus.
-9.74%
0.75-0.9x CRK's -12.56%. Bill Ackman questions if the competitor invests more robustly in future growth.
No Data
No Data available this quarter, please select a different quarter.
-16.61%
1.25-1.5x CRK's -11.08%. Bruce Berkowitz sees a stronger asset build. Check if it's producing returns.
-8.76%
Less than half of CRK's -47.71%. David Dodd sees a more disciplined AP approach or lower volume.
-100.00%
Higher Short-Term Debt Growth compared to CRK's zero value, indicating worse performance.
-87.50%
Below half of CRK's 114.67%. David Dodd notes smaller yoy tax burden vs. competitor. Check consistent profit levels.
-100.00%
Both CRK and the company show zero Deferred Revenue (Current) Growth.
-49.60%
Higher Other Current Liabilities Growth compared to CRK's zero value, indicating worse performance.
-45.47%
1.25-1.5x CRK's -32.96%. Martin Whitman is wary of bigger short-term burdens.
3.16%
Less than half of CRK's -1.02%. David Dodd sees more deleveraging vs. competitor.
1.26%
Higher Non-Current Deferred Revenue Growth compared to CRK's zero value, indicating better performance.
-75.79%
1.1-1.25x CRK's -63.37%. Bill Ackman questions if the firm is deferring more taxes than competitor.
-28.75%
Less than half of CRK's -88.49%. David Dodd notes more conservative expansions in non-current obligations.
-5.86%
Similar yoy to CRK's -5.72%. Walter Schloss sees parallel expansions in long-term liabilities.
No Data
No Data available this quarter, please select a different quarter.
-15.71%
Above 1.5x CRK's -8.38%. Michael Burry sees a potential leverage warning sign.
0.37%
1.1-1.25x CRK's 0.32%. Bill Ackman questions if the firm is issuing more stock than competitor.
-48.56%
Similar yoy to CRK's -46.91%. Walter Schloss sees parallel earnings retention vs. competitor.
-4.54%
Above 1.5x CRK's -2.62%. Michael Burry sees a significant jump in intangible or market-based gains. Scrutinize risk of reversal.
-0.37%
Higher Other Stockholders' Equity Items Growth compared to CRK's zero value, indicating worse performance.
-17.86%
Similar yoy to CRK's -16.85%. Walter Schloss sees parallel net worth trends.
-16.61%
1.25-1.5x CRK's -11.08%. Bruce Berkowitz checks if expansions are well-justified by ROI.
-15.38%
Both CRK and the company show zero Total Investments Growth.
-12.14%
Above 1.5x CRK's -1.02%. Michael Burry sees a major jump. Investigate leverage rationale.
6.34%
Similar yoy changes to CRK's 7.25%. Walter Schloss sees parallel net leverage strategies.
